RP
ZBH icon

Riverwater Partners’s Zimmer Biomet ZBH Stock Holding History

Riverwater Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,137
Closed -$232K – 219
2024
Q2 		$232K Sell
2,137
-33
-2% -$3.89K 0.17% 164
2024
Q1 		$286K Sell
2,170
-82
-4% -$10.2K 0.21% 153
2023
Q4 		$274K Sell
2,252
-186
-8% -$20.8K 0.22% 152
2023
Q3 		$274K Sell
2,438
-58
-2% -$7.37K 0.25% 143
2023
Q2 		$363K Buy
2,496
+80
+3% +$10.9K 0.32% 98
2023
Q1 		$312K Sell
2,416
-146
-6% -$18.3K 0.29% 110
2022
Q4 		$327K Sell
2,562
-534
-17% -$62K 0.28% 113
2022
Q3 		$324K Buy
3,096
+501
+19% +$55K 0.32% 102
2022
Q2 		$273K Sell
2,595
-33
-1% -$3.92K 0.28% 132
2022
Q1 		$336K Sell
2,628
-16
-0.6% -$1.93K 0.55% 79
2021
Q4 		$326K Buy
+2,644
New +$346K 0.29% 135

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Riverwater Partners's ZBH Position: Q3 2024 in Review

Riverwater Partners sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,137 shares — an estimated $232K sold.

Riverwater Partners first reported a position in ZBH in Q4 2021 and held it in 11 quarters. The position peaked at $363K in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Riverwater Partners reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Riverwater Partners sold 2,137 Zimmer Biomet shares in Q3 2024, an estimated $232K.
  • Riverwater Partners first reported a position in Zimmer Biomet in Q4 2021 and held it in 11 quarters.
  • Riverwater Partners's Zimmer Biomet position peaked at $363K in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Riverwater Partners's 13F filing for Q3 2024, filed 22 Oct 2024.